0000899243-23-002974.txt : 20230130 0000899243-23-002974.hdr.sgml : 20230130 20230130162545 ACCESSION NUMBER: 0000899243-23-002974 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230126 FILED AS OF DATE: 20230130 DATE AS OF CHANGE: 20230130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Osborne William H CENTRAL INDEX KEY: 0001445187 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 23568123 MAIL ADDRESS: STREET 1: 1415 WEST 22ND STREET STREET 2: SUITE 1100 CITY: OAK BROOK STATE: IL ZIP: 60523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-26 0 0001501134 Invitae Corp NVTA 0001445187 Osborne William H C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 1 0 0 0 Common Stock 2023-01-26 4 A 0 70423 0.00 A 70423 D Stock Option (right to buy) 2.46 2023-01-26 4 A 0 28902 0.00 A 2033-01-26 Common Stock 28902 28902 D Shares issuable upon settlement of a restricted stock unit award that vests in four equal installments, with 1/4th of the total award vesting on each of February 15, 2024, 2025, 2026 and 2027, subject to continued service with the Issuer through the applicable vesting dates. Includes 70,423 shares of common stock issuable pursuant to restricted stock units that have not vested. Options vests over four years as follows: 25% of the shares vest on January 26, 2024, and 1/48th of the shares vest each month thereafter for the remaining three years, subject to continued service with the Issuer through the applicable vesting dates. /s/ Thomas R. Brida, Attorney-in-Fact 2023-01-30